Parenteral Drugs (India) Limited announced earnings results for the third quarter ended December 31, 2020. For the third quarter, the company announced total revenue was INR 20.489 million compared to INR 72.49 million a year ago. Net loss was INR 309.746 million compared to INR 261.376 million a year ago. Basic loss per share from continuing operations was INR 10.41 compared to INR 8.77 a year ago. For the nine months, total revenue was INR 96.348 million compared to INR 233.391 million a year ago. Net loss was INR 968.675 million compared to INR 821.38 million a year ago. Basic loss per share from continuing operations was INR 32.55 compared to INR 27.56 a year ago.